ADICET BIO
Adicet Bio is a biotechnology company engaged in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
ADICET BIO
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2014-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.adicetbio.com
Total Employee:
101+
Status:
Active
Contact:
650-503-9095
Email Addresses:
[email protected]
Total Funding:
243.63 M USD
Technology used in webpage:
Domain Not Resolving Google Maps Amazon IPv6 COVID-19 Mobile Optimized New Relic Akamai Hosted Comcast Drupal
Similar Organizations
Adnovate Clinical
Adnovate Clinical is a biotechnology industry.
AlphaThera
AlphaThera is a biotechnology industry.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Functional Biosciences
Functional Biosciences is a biotechnology industry firm.
Landmark Bio
Landmark Bio is a biotechnology industry.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
RAGE Biotech
RAGE Biotech is a biotechnology industry.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-01-27 | Applied Immune Technologies | Applied Immune Technologies acquired by Adicet Bio | N/A |
Investors List
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Adicet Bio
Johnson & Johnson Robotics and Digital Solutions
Johnson & Johnson Robotics and Digital Solutions investment in Series B - Adicet Bio
OrbiMed
OrbiMed investment in Series B - Adicet Bio
Samsung Ventures
Samsung Ventures investment in Series B - Adicet Bio
Pontifax
Pontifax investment in Series B - Adicet Bio
Regeneron
Regeneron investment in Series B - Adicet Bio
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Adicet Bio
OrbiMed
OrbiMed investment in Series A - Adicet Bio
Pontifax
Pontifax investment in Series A - Adicet Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-11-29 | Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer |
Official Site Inspections
http://www.adicetbio.com Semrush global rank: 4.78 M Semrush visits lastest month: 1.89 K
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Adicet Bio"
Leadership and Board of Directors for Adicet Bio
He is a board member with the Alliance for Cancer Gene Therapy, a non-for-profit organization committed to advancing new cancer cell and gene therapies, Chairman of the Board of Carbon …See details»
Adicet Bio Reports Second Quarter 2025 Financial Results and …
Jun 30, 2025 For more information, please visit our website at https://www.adicetbio.com. Forward-Looking Statements This press release contains “forward-looking statements” of Adicet within the …See details»
Adicet Bio - Crunchbase Company Profile & Funding
Adicet Bio is a biotechnology company discovering and developing first-in-class …See details»
Adicet Bio, Inc - LinkedIn
Adicet Bio, Inc | 9,856 followers on LinkedIn. At Adicet (Nasdaq: ACET), we are defined by our mission to deliver best-in-class gamma-delta T cell therapies for …See details»
Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in ...
Jul 24, 2025 REDWOOD CITY, Calif. & BOSTON, July 24, 2025--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell …See details»
Governance Highlights - Adicet Bio
Governance Highlights The Board of Directors of Adicet sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate …See details»
Press Releases | Adicet Bio
Apr 30, 2025 The Investor Relations website contains information about Adicet Bio's business for stockholders, potential investors, and financial analysts.See details»
Pipeline | Adicet Bio
Adicet Bio is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. …See details»
Adicet Bio Reports Second Quarter 2025 Financial ... - Business Wire
2 days ago Adicet Bio, Inc. Investor and Media Contacts Anne Bowdidge [email protected] Penelope Belnap Precision AQ 212-362-1200 …See details»
Adicet Bio Company Profile | Management and Employees List
Find contact information for Adicet Bio. Learn about their Research & Development, Business Services market share, competitors, and Adicet Bio's email format.See details»
Careers at Adicet Bio
The Adicet Bio team combines extensive scientific knowledge and experience with an exceptional drive to provide innovative therapies for patients and the physicians who treat them.See details»
Adicet Bio - 2025 Company Profile & Team - Tracxn
Jul 26, 2025 Adicet Bio - Developer of immune cell therapeutic solutions for the treatment of cancer. Public Company. Raised a total funding of $51M over 5 rounds from 19 investors.See details»
Adicet Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 For more information, please visit our website at https://www.adicetbio.com. Forward-Looking Statements This press release contains “forward-looking statements” of Adicet within the …See details»
Adicet Bio - Profiles & Contacts - Crunchbase
Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer Founded 2014Public Post-IPO Equity Redwood City, …See details»
Adicet Announces Completion of Merger with resTORbio
Sep 15, 2020 Adicet Bio., Inc. Investor and Media Contacts: Anne Bowdidge [email protected] Janhavi Mohite Stern Investor Relations, Inc. 212-362-1200 …See details»
Adicet Bio offices | Redwood City, CA 94065 | Boston, MA 02116
Adicet Bio offices, 1000 Bridge Parkway, Redwood City, CA 94065 and Adicet Bio, 200 Berkeley Street, 19th Floor, Boston, MA 02116See details»
Adicet Bio, Inc Overview | SignalHire Company Profile
Total funding of the company - $131M. To connect with Adicet Bio, Inc employee register on SignalHire. Organization Website adicetbio.com Social Links Phone Number 650-542-0034 …See details»
Adicet Bio - Overview, News & Similar companies | ZoomInfo.com
May 14, 2024 View Adicet Bio (www.adicetbio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Privacy Policy - Adicet Bio
Nov 1, 2024 To exercise any of these rights please let us know by contacting us at [email protected] or by contacting our DPO at [email protected]. 10. Data …See details»
Adicet Bio - Craft
Oct 29, 2024 Adicet Bio is a biotechnology company that develops therapies for cancer diseases. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) for selective tumor …See details»